TTLC27 Abstract Submission opens October 2!

TTLC27 offers a valuable opportunity to present your work, connect with colleagues, and receive meaningful feedback, with its timing between other major conferences making it an ideal venue to showcase ongoing research and emerging findings. Abstracts must be led and presented by a Fellow or Junior Faculty member (fellow, postdoctoral researcher, assistant professor, or junior clinical instructor) based in North America (Canada or the United States). These eligibility requirements apply only to the lead author/presenter; more senior faculty and pharmaceutical or biotechnology company employees may be included as co-authors.

Please review the Frequently Asked Questions, important dates, and submission guidelines carefully.